APA (7th ed.) Citation

Tse, D. T., Benedetto, P. W., Tse, B. C., & Feuer, W. J. (2022). Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy. American journal of ophthalmology, 240, 239-251. https://doi.org/10.1016/j.ajo.2022.03.027

Chicago Style (17th ed.) Citation

Tse, David T., Pasquale W. Benedetto, Brian C. Tse, and William J. Feuer. "Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy." American Journal of Ophthalmology 240 (2022): 239-251. https://doi.org/10.1016/j.ajo.2022.03.027.

MLA (9th ed.) Citation

Tse, David T., et al. "Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy." American Journal of Ophthalmology, vol. 240, 2022, pp. 239-251, https://doi.org/10.1016/j.ajo.2022.03.027.